Ontruzant 150 mg/1
trastuzumab · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Organon LLC
No Recall History
Plain English
Ontruzant is a injection, powder, lyophilized, for solution containing trastuzumab at 150 mg/1, taken intravenous. Manufactured by Organon LLC.
Key Facts
- Brand Name
- Ontruzant
- Generic Name
- trastuzumab
- NDC Code (Product)
78206-147- Manufacturer
- Organon LLC
- Strength
- 150 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761100
- Drug Class
- HER2/neu Receptor Antagonist [EPC]
- Marketing Start
- 06/01/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Ontruzant used for?
Ontruzant contains trastuzumab. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Ontruzant a controlled substance?
Ontruzant is not classified as a controlled substance by the DEA.
What is the generic name for Ontruzant?
The generic name for Ontruzant is trastuzumab. There are 11 other brand versions of trastuzumab.
What is the NDC code for Ontruzant 150 mg/1?
The NDC (National Drug Code) for Ontruzant 150 mg/1 is 78206-147, listed by Organon LLC.